DONOR DERIVED CELL FREE DNA ; % dd-cfDNA
Rs 52,000 Rs 40,000
23 % OFF
Donor - derived cell - free DNA (% dd - cfDNA) is a non - invasive blood test that measures the amount of DNA fragments circulating in the bloodstream that originate from the transplanted organ.By tracking changes in dd - cfDNA levels over time, it can help detect early signs of transplant rejection or other complications.This test offers a potential advantage over traditional biopsy methods by providing a less invasive and more frequent monitoring option.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
SUBMIT 8-10 ML WHOLE BLOOD OF RECIPIENT ONLY IN 2 STRECK CELL FREE DNA BCT TUBES AVAILABLE FROM TRUEMEDIX. GENTLY MIX BY INVERTING 8-10 TIMES. DO NOT MIX BLOOD SAMPLE VIGOROUSLY. SHIP AT ROOM TEMPERATURE. DO NOT REFRIGERATE OR FREEZE. RECIPIENT SAMPLE SHOULD BE COLLECTED NOT BEFORE 2 WEEKS POST-TRANSPLANTATION; RECIPIENT SHOULD NOT HAVE HAD BLOOD TRANSFUSION THAT CONTAINS WHITE BLOOD CELLS WITHIN THE PAST 30 DAYS (WASHED OR LEUKOCYTE-DEPLETED RBCS ARE ACCEPTABLE); RECIPIENT SHOULD NOT HAVE HAD A BIOPSY WITHIN PAST 24 HRS; RECIPIENT SHOULD NOT HAVE HAD MULTIPLE TRANSPLANTEDORGANS; RECIPIENT SHOULD NOT BE PREGNANT; DO NOT COLLECT SAMPLE OF RECIPIENT IF TRANSPLANT IS FROM A MONOZYGOTIC / IDENTICAL TWIN; DO NOT COLLECT SAMPLE OF RECIPIENT WHO HAS RECEIVED ALLOGENEIC BLOOD OR BONE MARROW TRANSPLANT. DULY FILLED CELL FREE DNA CLINICAL INFORMATION FORM IS MANDATORY.
TARGETED NGS
REPORT ON 15TH DAY EVENING 7PM
DULY FILLED CELL FREE DNA CLINICAL INFORMATION FORM IS MANDATORY. RECIPIENT SAMPLE SHOULD BE COLLECTED NOT BEFORE 2 WEEKS (14 DAYS) POST-TRANSPLANTAION. RECIPIENT SHOULD NOT HAVE HAD BLOOD TRANSFUSION THAT CONTAINS WHITE BLOOD CELLS WITHIN THE PAST 30 DAYS (WASHED OR LEUKOCYTE-DEPLETED RBCS ARE ACCEPTABLE) RECIPIENT SHOULD NOT HAVE HAD A BIOPSY WITHIN PAST 24 HRS. RECIPIENT SHOULD NOT HAVE HAD MULTIPLE TRANSPLANTED ORGANS. RECIPIENT SHOULD NOT BE PREGNANT. DO NOT COLLECT SAMPLE OF RECIPIENT OF A TRANSPLANT FROM A MONOZYGOTIC (IDENTICAL) TWIN. DO NOT COLLECT SAMPLE OF RECIPIENT WHO HAS RECEIVED ALLOGENEIC BLOOD OR BONE MARROW TRANSPLANT.
